Enzyme-Linked Immunosorbent Assay Market Share

Statistics for the 2023 & 2024 Enzyme-Linked Immunosorbent Assay market share, created by Mordor Intelligence™ Industry Reports. Enzyme-Linked Immunosorbent Assay share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Enzyme-Linked Immunosorbent Assay Industry

The enzyme-linked immunosorbent assay (ELISA) market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Abcam PLC, Merck kGaA, Bio-Rad Laboratories, Inc, Cell Biolabs, Inc, Promega Corporation, Zeus Scientific, Inc, Enzo Life Sciences, Inc, Arbor Assays, Inc, Biolegend, Agilient Technologies, Inc, J. Mitra & Co. Pvt Ltd, and others.

Enzyme-Linked Immunosorbent Assay Market Leaders

  1. Thermo Fisher Scientific

  2. Bio-Rad Laboratories, Inc

  3. Agilient Technologies, Inc

  4. Merck KGaA

  5. Promega Corporation

*Disclaimer: Major Players sorted in no particular order

Enzyme-Linked Immunosorbent Assay (ELISA) Market Concentration

Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)